Insider Transactions in Q1 2021 at Sarepta Therapeutics, Inc. (SRPT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2021
|
M Kathleen Behrens |
SELL
Open market or private sale
|
Direct |
5,000
-3.69%
|
$425,000
$85.76 P/Share
|
|
Mar 10
2021
|
M Kathleen Behrens |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.56%
|
$210,000
$42.3 P/Share
|
|
Mar 08
2021
|
Hans Lennart Rudolf Wigzell |
SELL
Open market or private sale
|
Direct |
10,000
-37.71%
|
$830,000
$83.51 P/Share
|
|
Mar 08
2021
|
Hans Lennart Rudolf Wigzell |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+27.38%
|
$340,000
$34.92 P/Share
|
|
Mar 03
2021
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
2,726
+2.05%
|
-
|
|
Mar 03
2021
|
Richard Barry |
BUY
Grant, award, or other acquisition
|
Direct |
2,726
+0.09%
|
-
|
|
Mar 03
2021
|
Ryan Edward Brown EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+43.06%
|
-
|
|
Mar 03
2021
|
William Ciambrone EVP |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Mar 03
2021
|
Ian Michael Estepan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+34.06%
|
-
|
|
Mar 03
2021
|
Mary Ann Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,726
+24.42%
|
-
|
|
Mar 03
2021
|
John C Martin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,726
+25.62%
|
-
|
|
Mar 03
2021
|
Claude Nicaise |
BUY
Grant, award, or other acquisition
|
Direct |
2,726
+18.7%
|
-
|
|
Mar 03
2021
|
Gilmore Neil O'Neill EVP, R&D & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+34.04%
|
-
|
|
Mar 03
2021
|
Louise Rodino Klapac Head of R&D, CSO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+40.36%
|
-
|
|
Mar 03
2021
|
Hans Lennart Rudolf Wigzell |
BUY
Grant, award, or other acquisition
|
Direct |
2,726
+14.17%
|
-
|